{"url":"https://lda.senate.gov/api/v1/filings/38132bc4-0f02-488b-b8dd-ef38aad3f00a/","filing_uuid":"38132bc4-0f02-488b-b8dd-ef38aad3f00a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2019,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/38132bc4-0f02-488b-b8dd-ef38aad3f00a/print/","filing_document_content_type":"text/html","income":"11250.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"James W. Rock","dt_posted":"2019-10-19T16:45:58.843000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4103 Avenue H","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Austin","registrant_state":"TX","registrant_zip":"78751","registrant":{"id":33545,"url":"https://lda.senate.gov/api/v1/registrants/33545/","house_registrant_id":30422,"name":"ROCK & ASSOCIATES","description":"Government relations consultant.","address_1":"517 C Street, NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES W. ROCK","contact_telephone":"+1 703-627-8226","dt_updated":"2025-02-03T11:57:31.624210-05:00"},"client":{"id":141945,"url":"https://lda.senate.gov/api/v1/clients/141945/","client_id":176,"name":"PRECISION PHARMACY","general_description":"Compounding Pharmacy.","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-06-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}